Several studies have found semaglutide to be effective for weight loss
Gallagher, D., & Kramer, C
Tirzepatide, a dual GIP/GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, appears to reduce persistent food-related thoughts that many describe as "food noise." While not a formal medical term, food noise refers to intrusive, constant thoughts about eating that can interfere with daily life
For in vivo metabolic analysis, mice were intraperitoneally injected with a 15 N-glutamine solution (40 mg/kg in PBS)
Consider Alternatives If Who Should Avoid Do not use if You have active cancer or a history of cancerIGF-1 can stimulate cell growth including potentially cancerous cells You are pregnant or breastfeedingeffects on fetal/infant development are unknown You have diabetic retinopathyIGF-1 may accelerate eye blood vessel growth You have uncontrolled diabetesblood sugar management becomes extremely difficult You are under 21can affect natural growth plate closure and hormonal development You've had allergic reactions to IGF-1 or similar peptides Use with caution if !You have any insulin resistance or pre-diabetesmonitor blood sugar very carefully !You take medications that affect blood sugar levelsinteractions can be dangerous !You have heart conditionsIGF-1 can cause cardiac tissue growth !You have kidney or liver issuesmay affect peptide metabolism !You have carpal tunnel syndromeIGF-1 can worsen symptoms !You have a family history of cancerdiscuss with your doctor first Administration How do I use it
Not everyone can afford to shell out $200 to $300 for Ozempic, but if this new pill can keep costs lower, it could go a long way in democratizing obesity care
